Table 2.
Baseline cytology diagnosis by institution and race in the STRIDES cohort, Dec. 23, 2017 – May 7, 2020
| UMMC | ||||||
|---|---|---|---|---|---|---|
| n (%) | Caucasian or White 2404 (29.4) |
AA or Black 5351 (65.6) |
Other 302 (3.7) |
Missing 104 (1.3) |
Total 8165 (32.9) |
P-Value |
| NILM | 2061 (85.7) | 4476 (83.7) | 262 (86.8) | 100 (93.4) | 6899 (84.5) | 0.082 |
| ASC-US | 116 (4.8) | 323 (6.0) | 17 (5.6) | 1 (0.9) | 457 (5.6) | |
| LSIL | 102 (4.2) | 271 (5.1) | 8 (2.7) | 3 (2.9) | 384 (4.7) | |
| ASC-H | 6 (0.3) | 25 (0.5) | 2 (0.7) | 0 | 33 (0.4) | |
| HSIL | 30 (1.3) | 78 (1.5) | 5 (1.7) | 0 | 113 (1.4) | |
| Endometrial/Glandular | 5 (0.2) | 20 (0.4) | 0 | 1 (0.0) | 26 (0.3) | |
| Unsatisfactory | 84 (3.5) | 158 (3.0) | 8 (2.7) | 3 (2.8) | 253 (3.1) | |
| MSDH | ||||||
| n (%) | Caucasian or White 4141 (24.9) |
AA or Black 9582 (57.6) |
Other 1552 (9.3) |
Missing 1354 (8.2) |
Total 16631 (67.1) |
P-Value |
| NILM | 3480 (84.0) | 8041 (83.9) | 1402 (90.3) | 1155 (85.3) | 14078 (84.7) | <0.001 |
| ASC-US | 277 (6.7) | 669 (7.0) | 62 (3.9) | 83 (6.1) | 1091(6.6) | |
| LSIL | 245 (5.9) | 624 (6.5) | 60 (3.9) | 99 (7.3) | 1028 (6.1) | |
| ASC-H | 24 (0.6) | 46 (0.5) | 6 (0.4) | 3 (0.2) | 79 (0.5) | |
| HSIL | 73 (1.8) | 142 (1.5) | 6 (0.4) | 10 (0.7) | 231 (1.4) | |
| Endometrial/Glandular | 8 (0.2) | 5 (0.1) | 0 | 0 | 13 (0.1) | |
| Unsatisfactory | 34 (0.8) | 55 (0.6) | 16 (1.0) | 6 (0.4) | 111 (0.6) | |
Abbreviations: AA = African American, NILM = negative for intraepithelial lesion or malignancy, ASC-US = atypical squamous cells of undetermined significance, LSIL = low grade squamous intraepithelial lesion, ASC-H = atypical squamous cells of undetermined significance, high grade HSIL = high grade squamous intraepithelial lesion, Endometrial/Glandular = combined cytology categories with glandular lesions, Unsatisfactory = unsatisfactory for evaluation.